Skip to content

Evaluating Ultrasound-Guided Needle Knife for Dupuytren's Contracture

Advancing Dupuytren's Contracture Treatment: a Clinical Prospective Study on Ultrasound-Guided Needle Knife Dissection

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06788847
Acronym
DC-US
Enrollment
30
Registered
2025-01-23
Start date
2025-01-19
Completion date
2026-01-19
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dupuytren Contracture

Keywords

Ultrasound-Guided Procedure, Dupuytrene's Contracture, Tubiana Grade, Fibrotic Cords Acupotomy, Functional Hand Recovery, Palmar Fascia Fibrosis

Brief summary

This study aims to evaluate the efficacy and safety of ultrasound-guided needle knife dissection in treating Dupuytren's contracture. The procedure is designed to improve hund function and minimize complications associated with the conventional surgical methods.

Detailed description

Dupuytren's contracture is a disease mainly characterized by the progressive fibrosis of the palmar fascia with subsequent hand deformity and dysfunction. The current study seeks to explore, through this minimally invasive technique, ultrasound-guided needle knife dissection regarding ROM and patient satisfaction. The procedure will be carried out under ultrasound guidance to ensure safety and completeness with the accuracy of precise dissection. Primary outcome measures will concern hand mobility, and secondary measures will evaluate patient self-reported satisfaction and any complications for the 6-month follow-up period.

Interventions

PROCEDUREUltrasound guided needle knife dissection

This procedure involves a minimally invasive dissection of the fibrous cords in Dupuytren's Contracture using a needle knife guided by ultrasound imaging. Local anesthesia using 3-5 ml of 1% Lidocaine and 0.25% bupivacaine is administered for patient comfort. The technique aims to improve precision, minimize complications and reduce recurrence. Device: Sonosite M-Turbo Ultrasound Machine with Linear Probe HFL38x (6-13 MHz) is used for real-time imaging during the procedure.

Sponsors

Mohamed Maher Ismail Ahmed Elashmawy
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

All participants will undergo ultrasound-guided needle knife dissection for Dupuytren's Contracture treatment.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants diagnosed with Dupuytren's Contracture. * Willing to undergo ultrasound-guided needle knife dissection

Exclusion criteria

* Patients who have undergone previous surgery or needle apponeurotomy for Dupuytren's Contracture on the same hand. * Active hand infections, open wounds, or dermatological conditions in the treatment area. * Coagulopathy or use of anticoagulant that cannot be safely paused * Neuromuscular disorders affecting hand function * Pregnancy or breastfeeding * Uncontrolled systemic illnesses, such as poorly managed diabetes or cardiovascular disease. * Known hypersensitivity to local anesthetics.

Design outcomes

Primary

MeasureTime frameDescription
Improvement in hand Function6 monthsFunctional Improvement: \- Evaluated using the QuickDASH score (0-100 scale).
Improvement in hand mobility6 monthsRange of Motion (ROM): \- Measurment of joint mobility in degrees at MCP and PIP joints by goniometer.

Secondary

MeasureTime frameDescription
Patient Satisfaction6 monthsEvaluation of patient-reported satisfaction using a standardized questionnaire.
Rate of procedure-related complications6 monthsMonitoring and documentation of procedure-related complications, including infection, nerve injury, and other adverse events.

Countries

Egypt

Contacts

Primary ContactMohamed Maher Elashmawy, MD, PHD.
mohamedmaherismail@mans.edu.eg+201004303100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026